Literature DB >> 12461703

Resistance of lymphocytes to Fas-mediated apoptosis in Behçet's disease and Vogt-Koyangi-Harada syndrome.

Peizeng Yang1, Ling Chen, Hongyan Zhou, Huahong Zhong, Hong Wang, Xiangkun Huang, Aize Kijlstra.   

Abstract

BACKGROUND: Behçet's disease and Vogt-Koyanagi-Harada (VKH) syndrome are characterized by a severe intraocular inflammation with a long course and recurrent episodes. Activated autoreactive lymphocytes are considered to be responsible for the development of this inflammation. These lymphocytes may also be involved in the perpetuation and recurrence of this inflammation if they do not properly go into apoptosis. To investigate this hypothesis, a study was carried out to evaluate the resistance of lymphocytes to apoptosis in these two uveitis entities.
METHODS: Blood samples were obtained from 17 patients with Behçet's disease, 15 patients with VKH syndrome, and 11 healthy individuals. Mononuclear cells were isolated by centrifugation with Ficoll-Paque and cultured in RPMI 1640 with or without phytohemagglutinin (PHA) for 9 h at 37 degrees C in an atmosphere with 5% CO( 2). The obtained cells were incubated with anti-Fas antibody for 8 h at 37 degrees C in an atmosphere with 5% CO(2). The cells were stained with annexin V/propidium iodide and finally subjected to flow cytometry.
RESULTS: A significantly lower percentage of apoptotic lymphocytes after PHA stimulation was noted in Behçet's disease (19.7 +/- 4.1%) and VKH syndrome (20.4 +/- 6.9%) than in controls (26.1 +/- 7.3%). The percentage of apoptotic lymphocytes without PHA stimulation also tended to be lower in the patients with Behçet's disease (12.6%) and with VKH syndrome (12.8%) than in controls (14.6%), although the difference was not significant.
CONCLUSION: Lymphocytes in patients with either Behçet's disease or VKH syndrome are relatively resistant to apoptosis mediated by anti-Fas antibody. These apoptosis-resistant, or long-lived, lymphocytes may be involved in the chronic and recurrent intraocular inflammation seen in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461703     DOI: 10.1076/ocii.10.1.47.10331

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  7 in total

1.  Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.

Authors:  Tamer A Gheita; Iman H Bassyouni; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-07-26       Impact factor: 8.317

2.  Label-free proteomics reveals decreased expression of CD18 and AKNA in peripheral CD4+ T cells from patients with Vogt-Koyanagi-Harada syndrome.

Authors:  Liming Mao; Peizeng Yang; Shengping Hou; Fuzhen Li; Aize Kijlstra
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

Review 3.  Functional role of apoptosis in oral diseases: An update.

Authors:  Akansha Misra; Shalu Rai; Deepankar Misra
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

4.  Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.

Authors:  Antonio Puccetti; Piera Filomena Fiore; Andrea Pelosi; Elisa Tinazzi; Giuseppe Patuzzo; Giuseppe Argentino; Francesca Moretta; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-04-24       Impact factor: 4.818

5.  Baculoviral inhibitor of apoptosis family of proteins repeat-containing 5 gene methylation status in peripheral blood mononuclear cells and plasma survivin levels in patients with Behçet's disease.

Authors:  Yasamin Pahlavan; Alireza Khabbazi
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

6.  Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.

Authors:  Sébastien Abad; Grégoire Wieërs; Didier Colau; Claude Wildmann; Emmanuelle Delair; Robin Dhote; Antoine P Brézin; Yukata Kawakami; Pierre G Coulie; Pierre van der Bruggen
Journal:  Mol Vis       Date:  2014-07-02       Impact factor: 2.367

7.  Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet's disease.

Authors:  Jieying Qin; Lin Li; Donglei Zhang; Hongsong Yu; Handan Tan; Jun Zhang; Bolin Deng; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.